Papillary Thyroid Carcinoma
Conditions
Interventions
Thyroidectomy/Lobectomy:None
Thermal Ablation:None
Sponsors
Beijing Friendship Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with pathologically confirmed papillary thyroid carcinoma (PTC) (MWA group diagnosed via pre-ablation fine-needle aspiration [FNA]; TT/LT group diagnosed via intraoperative pathological examination); 2.Maximum tumor diameter <= 2 cm (according to the AJCC TNM staging system: T1a for tumors with diameter d <= 1 cm, and T1b for tumors with 1 cm < d <=2 cm); 3.No clinical or radiological evidence of extrathyroidal extension, cervical lymph node metastasis, or distant metastasis.
Exclusion criteria
Exclusion criteria: 1.Coexisting diffuse thyroid lesions (determined by ultrasound imaging showing diffuse changes and/or elevated thyroid antibodies in the MWA group; diagnosed via intraoperative pathological examination in the TT/LT group); 2.Evidence of extrathyroidal extension, cervical lymph node metastasis, or distant metastasis (confirmed by imaging or pathology: in the MWA group, based on ultrasound findings such as cancer foci adjacent to the thyroid capsule causing mild distortion or interruption of the capsule or bulging gland contours; in the TT/LT group, based on intraoperative pathological analysis); 3.Maximum follow-up duration < 6 months or incomplete data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-Free Survival, DFS;Incidence of local recurrence/lymph node metastasis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse effects to TSH suppression therapy; | — |
Countries
China
Contacts
Public ContactQian Linxue
Beijing Friendship Hospital, Capital Medical University
Outcome results
None listed